Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Effect of testosterone replacement therapy on vitamin D and FGF-23 levels in congenital hypogonadism.

Haymana C, Sonmez A, Aydogdu A, Tapan S, Basaran Y, Meric C, Baskoy K, Taslipinar A, Yilmaz MI, Azal O.

Endokrynol Pol. 2017;68(3):311-616. doi: 10.5603/EP.a2017.0009. Epub 2017 Feb 23.

2.

Visceral adiposity index and triglyceride/high-density lipoprotein cholesterol ratio in hypogonadism.

Haymana C, Sonmez A, Aydogdu A, Tapan S, Basaran Y, Meric C, Baskoy K, Dinc M, Yazici M, Taslipinar A, Barcin C, Yilmaz MI, Bolu E, Azal O.

Arch Endocrinol Metab. 2017 May-Jun;61(3):282-287. doi: 10.1590/2359-3997000000236. Epub 2017 Feb 13.

3.

Add on Exenatide Treatment is Beneficial in Poorly Controlled Obese Type 2 Diabetics under Intensive Insulin Regimens.

Sönmez A, Dinç M, Taşlıpınar A, Aydoğdu A, Meriç C, Başaran Y, Haymana C, Demir O, Yılmaz İ, Azal Ö.

Exp Clin Endocrinol Diabetes. 2017 Apr;125(4):256-261. doi: 10.1055/s-0042-120708. Epub 2017 Feb 15.

PMID:
28201828
4.

Real-Time Ultrasound Elastographic Features of Primary Open Angle Glaucoma.

Unal O, Cay N, Yulek F, Taslipinar AG, Bozkurt S, Gumus M.

Ultrasound Q. 2016 Dec;32(4):333-337.

PMID:
27599308
5.

A Rare Reason of Hyperinsulinism: Munchausen Syndrome by Proxy.

Akın O, Yeşilkaya E, Sari E, Akar Ç, Başbozkurt G, Macit E, Aydin I, Taşlipinar A, Gül H.

Horm Res Paediatr. 2016;86(6):416-419. doi: 10.1159/000446497. Epub 2016 May 26.

PMID:
27221098
6.

Thyrotropinoma with Graves' disease detected by the fusion of indium-111 octreotide scintigraphy and pituitary magnetic resonance imaging.

Okuyucu K, Alagoz E, Arslan N, Taslipinar A, Deveci MS, Bolu E.

Indian J Nucl Med. 2016 Apr-Jun;31(2):141-3. doi: 10.4103/0972-3919.178322.

7.

An unusual presentation of primary hyperparathyroidism: multiple brown tumors and coexisting thyroid carcinoma.

Basaran Y, Ince S, Alagoz E, Meric C, Taslipinar A.

Rev Esp Med Nucl Imagen Mol. 2016 Sep-Oct;35(5):321-4. doi: 10.1016/j.remn.2016.02.005. Epub 2016 Mar 29. English, Spanish.

PMID:
27036887
8.

Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey.

Aydoğan Bİ, Yüksel B, Tuna MM, Navdar Başaran M, Akkurt Kocaeli A, Ertörer ME, Aydın K, Güldiken S, Şimşek Y, Cihan Karaca Z, Yılmaz M, Aktürk M, Anaforoğlu İ, Kebapçı N, Duran C, Taşlıpınar A, Kulaksızoğlu M, Gürsoy A, Dağdelen S, Erdoğan MF.

J Clin Res Pediatr Endocrinol. 2016 Mar 5;8(1):13-20. doi: 10.4274/jcrpe.2219. Epub 2015 Dec 18.

9.

Erratum to: Trace Element Levels in Congenital Hypogonadotrophic Hypogonadism.

Aydogdu A, Haymana C, Soykut B, Erdem O, Basaran Y, Baskoy K, Dinc M, Taslipinar A, Sonmez A, Bolu E, Azal O.

Biol Trace Elem Res. 2016 May;171(1):33. doi: 10.1007/s12011-015-0539-5. No abstract available.

PMID:
26494238
10.

Trace Element Levels in Congenital Hypogonadotrophic Hypogonadism.

Aydogdu A, Haymana C, Soykut B, Erdem O, Basaran Y, Baskoy K, Dinc M, Taslipinar A, Sonmez A, Bolu E, Azal O.

Biol Trace Elem Res. 2016 May;171(1):26-32. doi: 10.1007/s12011-015-0496-z. Epub 2015 Sep 7. Erratum in: Biol Trace Elem Res. 2016 May;171(1):33.

PMID:
26343359
11.

Clinicopathologic features and prognostic factors of tall cell variant of papillary thyroid carcinoma: comparison with classic variant of papillary thyroid carcinoma.

Okuyucu K, Alagoz E, Arslan N, Emer O, Ince S, Deveci S, Ayan A, Taslipinar A, Gunalp B, Azal O.

Nucl Med Commun. 2015 Oct;36(10):1021-5. doi: 10.1097/MNM.0000000000000360.

PMID:
26225942
12.

Endothelial dysfunction, insulin resistance and inflammation in congenital hypogonadism, and the effect of testosterone replacement.

Sonmez A, Haymana C, Aydogdu A, Tapan S, Basaran Y, Meric C, Baskoy K, Dinc M, Yazici M, Taslipinar A, Barcin C, Yilmaz MI, Bolu E, Azal O.

Endocr J. 2015;62(7):605-13. doi: 10.1507/endocrj.EJ15-0125. Epub 2015 May 28.

13.

Endothelial dysfunction and insulin resistance in young women with polycystic ovarian syndrome.

Yavuz Taşlipinar M, Kiliç N, Bayraktar N, Güler İ, Gülcan Kurt Y, Göktaş T, Taner MZ, Hımmetoğlu MÖ, Yaman H, Taşlipinar A.

Turk J Med Sci. 2014;44(5):787-91.

PMID:
25539546
14.

Osteoprotegerin, fibroblast growth factor 23, and vitamin D3 levels in male patients with hypogonadism.

Meric C, Sonmez A, Aydogdu A, Tapan S, Haymana C, Basaran Y, Baskoy K, Sertoglu E, Taslipinar A, Bolu E, Azal O.

Horm Metab Res. 2014 Dec;46(13):955-8. doi: 10.1055/s-0034-1387789. Epub 2014 Sep 2.

PMID:
25181418
15.
16.

The effect of levothyroxine replacement therapy on lipid profile and oxidative stress parameters in patients with subclinical hypothyroid.

Mutlu S, Parlak A, Aydogan U, Aydogdu A, Soykut B, Akay C, Saglam K, Taslipinar A.

Arch Pharm Res. 2013 Aug 8. [Epub ahead of print]

PMID:
23925559
17.

HDL cholesterol subfractions and the effect of testosterone replacement in hypogonadism.

Bolu E, Sonmez A, Tapan S, Taslipinar A, Aydogdu A, Meric C, Basaran Y, Uckaya G, Serdar M, Kurt I, Azal O.

Horm Metab Res. 2013 Jun;45(6):443-8. doi: 10.1055/s-0033-1343447. Epub 2013 Apr 23.

PMID:
23613012
18.

Effects of three different medications on metabolic parameters and testicular volume in patients with hypogonadotropic hypogonadism: 3-year experience.

Aydogdu A, Bolu E, Sonmez A, Tasci I, Haymana C, Acar R, Meric C, Taslipinar A, Ozgurtas T, Azal O.

Clin Endocrinol (Oxf). 2013 Aug;79(2):243-51. doi: 10.1111/cen.12135. Epub 2013 May 6.

PMID:
23278834
19.

Women with polycystic ovary syndrome have increased plasma chitotriosidase activity: a pathophysiological link between inflammation and impaired insulin sensitivity?

Aydogdu A, Tasci I, Tapan S, Sonmez A, Aydogan U, Akbulut H, Uckaya G, Aydogdu S, Basaran Y, Meric C, Taslipinar A, Kurt I, Azal O.

Exp Clin Endocrinol Diabetes. 2012 May;120(5):261-5. doi: 10.1055/s-0032-1309010. Epub 2012 Apr 27.

PMID:
22549343
20.

High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.

Aydogdu A, Tasci I, Tapan S, Basaran Y, Aydogan U, Meric C, Sonmez A, Aydogdu S, Akbulut H, Taslipinar A, Uckaya G, Azal O.

Gynecol Endocrinol. 2012 Sep;28(9):722-5. doi: 10.3109/09513590.2011.652719. Epub 2012 Feb 4.

PMID:
22304663
21.

Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD.

Carrero JJ, Kyriazis J, Sonmez A, Tzanakis I, Qureshi AR, Stenvinkel P, Saglam M, Stylianou K, Yaman H, Taslipinar A, Vural A, Gok M, Yenicesu M, Daphnis E, Yilmaz MI.

Clin J Am Soc Nephrol. 2012 Feb;7(2):207-15. doi: 10.2215/CJN.06840711. Epub 2011 Dec 22.

22.

Comment on: Jones et al. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 Study). Diabetes Care 2011;34:828-837.

Sonmez A, Taslipinar A, Tapan S, Serdar MA.

Diabetes Care. 2011 Nov;34(11):e172; author's reply e173. doi: 10.2337/dc11-1292. No abstract available.

23.

The relationship between inflammation, endothelial dysfunction and proteinuria in patients with diabetic nephropathy.

Taslipinar A, Yaman H, Yilmaz MI, Demirbas S, Saglam M, Taslipinar MY, Agilli M, Kurt YG, Sonmez A, Azal O, Bolu E, Yenicesu M, Kutlu M.

Scand J Clin Lab Invest. 2011 Nov;71(7):606-12. doi: 10.3109/00365513.2011.598944. Epub 2011 Aug 24.

PMID:
21864054
24.

Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease.

Yilmaz MI, Sonmez A, Qureshi AR, Saglam M, Stenvinkel P, Yaman H, Eyileten T, Caglar K, Oguz Y, Taslipinar A, Vural A, Gok M, Unal HU, Yenicesu M, Carrero JJ.

Clin J Am Soc Nephrol. 2011 Jul;6(7):1617-25. doi: 10.2215/CJN.10681210. Epub 2011 Jun 23.

25.

Electrophysiological assessment of the autonomic nervous system in male patients with acromegaly.

Oz O, Taşlıpınar A, Yücel M, Akgün H, Ulaş UH, Bolu E, Kütükçü Y, Odabaşı Z.

Eur Neurol. 2011;66(1):1-5. doi: 10.1159/000328025. Epub 2011 Jun 1.

PMID:
21646783
26.

Metabolic syndrome and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism.

Sonmez A, Haymana C, Bolu E, Aydogdu A, Tapan S, Serdar M, Altun B, Barcin C, Taslipinar A, Meric C, Uckaya G, Kutlu M.

Eur J Endocrinol. 2011 May;164(5):759-64. doi: 10.1530/EJE-10-0951. Epub 2011 Feb 16.

PMID:
21325471
27.

Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus.

Sonmez A, Haymana C, Tapan S, Safer U, Celebi G, Ozturk O, Genc H, Dogru T, Tasci I, Erdem G, Taslipinar A, Aydogdu A, Yilmaz MI, Kurt I, Kutlu M.

Endocrine. 2010 Jun;37(3):455-9. doi: 10.1007/s12020-010-9334-4. Epub 2010 Apr 11.

PMID:
20960168
28.

The accuracy of home glucose meters in hypoglycemia.

Sonmez A, Yilmaz Z, Uckaya G, Kilic S, Tapan S, Taslipinar A, Aydogdu A, Yazici M, Yilmaz MI, Serdar M, Erbil MK, Kutlu M.

Diabetes Technol Ther. 2010 Aug;12(8):619-26. doi: 10.1089/dia.2009.0183.

PMID:
20615103
29.

Cutaneous silent period changes in Type 2 diabetes mellitus patients with small fiber neuropathy.

Onal MR, Ulas UH, Oz O, Bek VS, Yucel M, Taslipinar A, Odabasi Z.

Clin Neurophysiol. 2010 May;121(5):714-8. doi: 10.1016/j.clinph.2009.12.024. Epub 2010 Feb 6.

PMID:
20138004
30.

Relationship between hemoglobin and CD40 ligand in prediabetes.

Kutlu M, Sonmez A, Genc H, Erdem G, Tapan S, Celebi G, Haymana C, Taslipinar A, Uckaya G, Erbil MK.

Clin Invest Med. 2009 Dec 1;32(6):E244.

PMID:
20003829
31.

Ovotesticular disorder of sex development with a prostatic gland and review of literature.

Irkilata HC, Basal S, Taslipinar A, Gur A, Piskin MM, Kurt B, Tahmaz L, Bolu E, Dayanc M.

Andrologia. 2009 Dec;41(6):387-91. doi: 10.1111/j.1439-0272.2009.00945.x. Review.

PMID:
19891638
32.

Evaluation of breast enlargement in young males and factors associated with gynecomastia and pseudogynecomastia.

Yazici M, Sahin M, Bolu E, Gok DE, Taslipinar A, Tapan S, Torun D, Uckaya G, Kutlu M.

Ir J Med Sci. 2010 Dec;179(4):575-83. doi: 10.1007/s11845-009-0345-1. Epub 2009 Jun 4.

PMID:
19495841
33.

Prediction of testosterone response to human chorionic gonadotrophin in idiopathic hypogonadotropic hypogonadism patients.

Yazici M, Sahin M, Bolu E, Uckaya G, Gok DE, Taslipinar A, Ozgurtas T, Kutlu M.

J Natl Med Assoc. 2009 Jan;101(1):71-6.

PMID:
19245075
34.

Complementary and alternative medicine use among Turkish diabetes patients.

Ceylan S, Azal O, Taşlipinar A, Türker T, Açikel CH, Gulec M.

Complement Ther Med. 2009 Apr;17(2):78-83. doi: 10.1016/j.ctim.2008.07.003. Epub 2008 Sep 21.

PMID:
19185265
35.

Comparison of 1 mg and 2 mg overnight dexamethasone suppression tests for the screening of Cushing's syndrome in obese patients.

Sahin M, Kebapcilar L, Taslipinar A, Azal O, Ozgurtas T, Corakci A, Akgul EO, Taslipinar MY, Yazici M, Kutlu M.

Intern Med. 2009;48(1):33-9. Epub 2009 Jan 1.

36.

Insulin-like growth factor-1 is essential to the increased mortality caused by excess growth hormone: a case of thyroid cancer and non-Hodgkin's lymphoma in a patient with pituitary acromegaly.

Taslipinar A, Bolu E, Kebapcilar L, Sahin M, Uckaya G, Kutlu M.

Med Oncol. 2009;26(1):62-6. doi: 10.1007/s12032-008-9084-9. Epub 2008 Jul 29.

PMID:
18663612
37.

Increased serum chitotriosidase activity following restoration of euthyroidism in patients with subclinical hypothyroidism.

Erdal M, Sahin M, Saglam K, Hasimi A, Uckaya G, Yarpuz MY, Taslipinar A, Gharib H, Kutlu M.

Intern Med. 2008;47(14):1309-14. Epub 2008 Jul 15.

38.

HDR syndrome (hypoparathyroidism, sensorineural deafness and renal disease) accompanied by renal tubular acidosis and endocrine abnormalities.

Taslipinar A, Kebapcilar L, Kutlu M, Sahin M, Aydogdu A, Uckaya G, Azal O, Bolu E, Ibrahim Aydin H.

Intern Med. 2008;47(11):1003-7. Epub 2008 Jun 2.

39.

Leptin, soluble interleukin-6 receptor, C-reactive protein and soluble vascular cell adhesion molecule-1 levels in human coronary atherosclerotic plaque.

Karaduman M, Oktenli C, Musabak U, Sengul A, Yesilova Z, Cingoz F, Olgun A, Sanisoglu SY, Baysan O, Yildiz O, Taslipinar A, Tatar H, Kutlu M, Ozata M.

Clin Exp Immunol. 2006 Mar;143(3):452-7.

40.

Subacute cholestatic hepatitis likely related to the use of senna for chronic constipation.

Sonmez A, Yilmaz MI, Mas R, Ozcan A, Celasun B, Dogru T, Taslipinar A, Kocar IH.

Acta Gastroenterol Belg. 2005 Jul-Sep;68(3):385-7.

PMID:
16268429
41.

Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients.

Baykal Y, Saglam K, Yilmaz MI, Taslipinar A, Akinci SB, Inal A.

Clin Rheumatol. 2003 May;22(2):99-101.

PMID:
12740672

Supplemental Content

Loading ...
Support Center